PGEN · Precigen, Inc. · Webcasts, Transcripts & Audio
$7.66
-0.08 (-1.03%)
At close · Oct 6
View the 10-Q filed May 13, 2026
Return incl. dividend (before tax)
Customer concentration
— key customers 49.9% of revenue
Key customers — 49.9% of revenue (the three months ended March 31, 2025)
“For the three months ended March 31, 2025, four customers accounted for 49.9% of total condensed consolidated revenues.”
Market Cap
$2.77B
Shares
358.04M
Volume · Oct 5
10.25M
Avg daily vol (3M)
5.05M
Precigen, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Precigen, Inc. (PGEN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲13.7%
$19.33M
−$41.66M
'20 Q4
21-03-01
▼87.5%
$3.81M
−$20.05M
'21 Q2
21-08-09
▼85.9%
$3.33M
−$29.76M
'21 Q3
21-11-04
▼23.7%
$2.91M
−$17.64M
'22 Q2
22-08-08
▲401.7%
$16.72M
$87.38M
'22 Q3
22-11-09
·
$1.76M
−$22.18M
'22 Q4
23-01-24
▼66.4%
$1.85M
−$22.73M
'23 Q1
23-05-10
▼39.3%
$1.77M
−$20.32M
'23 Q2
23-08-09
·
$1.34M
−$54.15M
'25 Q1
25-05-14
▲1633.9%
$23.25M
−$7.93M
'26 Q1
26-05-13
LATEST
▲6322.7%
$54.98M
$20.07M
'26 Q2
26-08-04
Earnings call
FY26 · Q2
2026-08-04
Precigen, Inc. (PGEN) Q2 2026 Earnings Call
Revenue
$54.98M
▲ 6322.7% YoY Diluted EPS
$0.05
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
Precigen, Inc. (PGEN) Q1 2026 Earnings Call Transcript
Confident tone
PAPZIMEOS launch trajectory
ASCO durability data and label expansion
Payer coverage and access
Revenue
$23.25M
▲ 1633.9% YoY Diluted EPS
$-0.02
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-25
Precigen, Inc. (PGEN) Q4 2025 Earnings Call Transcript
Confident tone
RRP disease and standard of care
Patient and prescriber adoption
Payer coverage and reimbursement
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-13
Precigen, Inc. (PGEN) Q3 2025 Earnings Call Transcript
Confident tone
Papcemias approval and clinical profile
Geographic expansion
Redosing and label expansion
Diluted EPS
$-1.06
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Precigen, Inc. (PGEN) Q1 2025 Earnings Call
Revenue
$1.34M
Diluted EPS
$-0.18
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-14
Precigen, Inc. (PGEN) Q2 2024 Earnings Call Transcript
Confident tone
PRGN-2012 lead asset for RRP
Commercial launch preparation
Confirmatory trial and regulatory path
Diluted EPS
$-0.23
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-14
Precigen, Inc. (PGEN) Q1 2024 Earnings Call
Diluted EPS
$-0.10
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-19
Precigen, Inc. (PGEN) Q4 2023 Earnings Call Transcript
Confident tone
PRGN-2012 lead asset / RRP
Commercial readiness and launch planning
Phase 2 data and regulatory pathway
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q2
2023-08-09
Precigen, Inc. (PGEN) Q2 2023 Earnings Call Transcript
Revenue
$1.77M
▼ 39.3% YoY Diluted EPS
$-0.08
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
Precigen, Inc. (PGEN) Q1 2023 Earnings Call Transcript
Revenue
$1.85M
▼ 66.4% YoY Diluted EPS
$-0.10
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-24
Precigen, Inc. (PGEN) Q4 2022 Earnings Call
Revenue
$1.76M*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-09
Precigen, Inc. (PGEN) Q3 2022 Earnings Call Transcript
Revenue
$16.72M
▲ 401.7% YoY Diluted EPS
$0.44
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Precigen, Inc. (PGEN) Q2 2022 Earnings Call Transcript
Revenue
$2.91M
▼ 23.7% YoY Diluted EPS
$-0.09
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q3
2021-11-04
Precigen, Inc. (PGEN) Q3 2021 Earnings Call
Revenue
$3.33M
▼ 85.9% YoY Diluted EPS
$-0.15
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-09
Precigen, Inc. (PGEN) Q2 2021 Earnings Call Transcript
Revenue
$3.81M
▼ 87.5% YoY Diluted EPS
$-0.10
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-01
Precigen, Inc. (PGEN) Q4 2020 Earnings Call Transcript
Revenue
$19.33M
▲ 13.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Precigen, Inc. (PGEN) Q3 2020 Earnings Call
Revenue
$23.58M
▲ 28.9% YoY Diluted EPS
$-0.18
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Precigen, Inc. (PGEN) Q2 2020 Earnings Call Transcript
Revenue
$30.42M
▼ 7.3% YoY Diluted EPS
$-0.26
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-12
Precigen, Inc. (PGEN) Q1 2020 Earnings Call Transcript
Revenue
$29.84M
▲ 32.1% YoY Diluted EPS
$-0.35
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-02
Precigen, Inc. (PGEN) Q4 2019 Earnings Call
Revenue
$17.00M
▼ 58.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–20 of 20 webcasts